Company news
hVIVO plc news in 2019
hVIVO plc's news releases, calls and decks from 2019, newest first.
Offer Update
December 31, 2019
HVIVO PLC
December 19, 2019
New Contract with SFA Therapeutics
December 18, 2019
Recommended Merger of hVIVO with Open Orphan
December 9, 2019
Early adopters signed for Genomic Health DataBANK
November 25, 2019
Contract signed with Carna Bioscience
November 18, 2019
Jefferies 2019 London Healthcare Conference
November 15, 2019
Preferred Partner Agreement
November 11, 2019
Agreement signed with Empiric Logic
October 15, 2019
hVIVO to present at ERS International Congress
September 27, 2019
Interim Results for 6 months ended 30 June 2019
September 25, 2019
Interim Results 2019
September 19, 2019
Notice of Interim Results
August 23, 2019
Successful RSV Challenge Study in Older Adults
August 6, 2019
Directorate Changes
August 1, 2019
Phase 1 clinical trial of AGS-v PLUS
July 31, 2019
Integumen Shares
July 12, 2019
First Day of Dealings and Re-admission
June 28, 2019
Directorate Update
June 25, 2019
RSV Challenge Model Delivers Positive Results
June 17, 2019
Euronext Growth - Schedule One
June 14, 2019
Placing of Shares
June 11, 2019
Conditional Acquisition of Open Orphan DAC
May 10, 2019
Integumen Debt Conversion
May 1, 2019
2018 Annual Report and Financial Statements
April 26, 2019
Preliminary Results 2018
April 11, 2019
Financing Update
April 8, 2019
hVIVO and Imutex to present at IVW 2019
March 29, 2019
Change of Adviser
March 26, 2019
Notice of Preliminary Results
March 8, 2019
Share Incentive Plan and PDMR Dealings
January 24, 2019
Partnership Announcement
January 18, 2019
Positive data for Phase IIb FLU-v challenge study
January 10, 2019
Award of Share Options
January 4, 2019
Decks in 2019
- ERS International Congress 2019
Conference · 18 slides · September 2019